Cited by 13Pharmacy and Medical PracticesPharmaceutical Practices and Patient OutcomesMedication Adherence and Compliance

Effectiveness of home pharmaceutical interventions in metabolic syndrome: a randomized controlled trial

Open access
Azevedo, Maria da Glória Batista de, Pedrosa, Roseana Souza, Aoqui, Caroline Mapurunga, Martins, Rand Randall, Nagashima Junior, Toshiyuki·2017·Brazilian Journal of Pharmaceutical Sciences

Abstract

Metabolic syndrome (MetS) is a group of different risk factors that raises the chances of develop several health problems such, as cardiovascular disease and diabetes. There are few cases in literature of studies that specifically address the use of pharmaceutical care in MetS. The aim of study was to evaluate the effectiveness of home pharmaceutical interventions in patients with this syndrome. The randomized clinical trial was conducted in subjects with diagnosis of MetS treated in a basic unit of health from Cuité, Paraíba. The patients were randomized in a 1:1 ratio to two groups: intervention (IG) and control (CG). The IG received monthly individual pharmaceutical interventions, while the CG did not. The effectiveness of the intervention protocol was measured after six months, comparing the hemodynamic values, anthropometric, biochemistry, cardiovascular risk, medication adherence, drug related problems (DRP) and quality of life. The sample consisted of 63 individuals (33 IG and 30 CG) and older than 60 years. The majority of pharmaceutical interventions were educational and/or behavioral. In the intervention group, significant differences were observed in the parameters systolic and diastolic blood pressure, triglycerides, medication adherence and DRP. The pharmaceutical interventions at home were effective in improving medication adherence, decreasing DRPs and helping to control components of the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/s2175-97902017000216089

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Among studies reporting health outcomes, variability in standardisation of health outcomes and scoring interpretation, including instances of scoring in the opposite direction, precluded a meta-analysis of health outcomes and adverse effects.

    “Among studies reporting health outcomes, variability in standardisation of health outcomes and scoring interpretation, including instances of scoring in the opposite direction, precluded a meta-analysis of health outcomes49,53 and adverse effects.39,40,43,52”

    From Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis (2025) · cites this paper as [49]

    Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. CHARROIS, T.L.; ZOLEZZI, M.; KOSHMAN, S.L.; PEARSON, G.; MAKOWSKY, M.; DUREC, T.; TSUYUKI, R.T. A systematic review of the evidence for pharmacist care of patients with dyslipidemia. Pharmacotherapy, v.32, n.3, p.222-233, 2012.
  2. CHEEMA, E.; SUTCLIFFE, P.; SINGER, D.R.J. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br. J. Clin. Pharmacol., v.78, n.6, p.1238-1247, 2014.
  3. CHISHOLM-BURNS, M.A.; KIM LEE, J.; SPIVEY, C.A.; SLACK, M.; HERRIER, R.N.; HALL-LIPSY, E.; GRAFF ZIVIN, J.; ABRAHAM, I.; PALMER, J.; MARTIN, J.R.; KRAMER, S.S.; WUNZ, T. US pharmacists' effect as team members on patient care: systematic review and meta- analyses. Med. Care, v.48, n.10, p.923-933, 2010.
  4. JIN, J.; SKLAR, G.E.; SENOH, V.M.; LI, S.C. Factors affecting therapeutic compliance: A review from the patient's perspective. Ther. Clin. Risk Manag., v.4, n.1, p.269-286, 2008.
  5. KAUR, J. A comprehensive review on metabolic syndrome. Cardiol Res Pract, v. 2014, p. 1-21, 2014.
  6. RUSSELL, C.L.; CONN, V.S.; JANTARAKUPT, P. Older adult medication compliance: Integrated review of randomized controlled trials. Am. J. Health Behav., v.30, n.6, p.636- 650, 2006.
  7. SANTSCH, V.; CHIOLERO, A.; BURNAND, B.; COLOSIMO, A.L.; PARADIS, G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch. Intern. Med., v.171, n.16, p.1441-1453, 2011.
  8. ZERMANSKY, A.G.; ALLDRED, D.P.; PETTY, D.R.; RAYNOR, D.K.; FREEMANTLE, N.; EASTAUGH, J.; BOWIE, P. Clinical medication review by a pharmacist of elderly people living in care homes -randomised controlled trial. Age Ageing, v.35, n.6, p.586-591, 2006.

Cited by

Sorted by citations

Authors
Azevedo, M. D. G. B. D., Pedrosa, R. S., Aoqui, C. M., Martins, R. R., & Nagashima Junior, T.
Affiliations
  • Universidade Estadual da Paraíba (BR)
  • Universidade Federal de Campina Grande (BR)
  • Universidade Federal do Rio Grande do Norte (BR)
  • Federal University of Campina Grande, Brazil
Venue
Brazilian Journal of Pharmaceutical Sciences
Published
2017
Volume
53
Issue
2
ISSN
1984-8250 (ISSN-L)
OpenAlex
W2646412555
Cited by
13
References
2
Citations by year
2025: 1 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 1 · 2014: 1
FWCI
2.05
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Brazilian Journal of Pharmaceutical Sciences (publishedVersion, cc-by)
  • Americanae (AECID Library) (publishedVersion, other-oa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
Keywords
metabolic syndrome, pharmaceutical care, medication adherence, drug-related problems, blood pressure control, triglycerides, cardiovascular risk, quality of life, older adults, primary care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review